Forums. Cleansing notice39. Seriously! In June the interim dipg data is July/August, then they move it to Q3, now it is November!!! The remuneration vote will make history and we. ASX - Short Term Trading. Created with Sketch. Notification of cessation of securities - KZACreated with Sketch. 12% gap between the sell and buy orders now. 49% 8. Now this presentation tonight makes reference to KZA Phase 2 trial. Share Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Join the HotCopper ASX share market forum today for free. 1. ASX - Day Trading. Pure speculation but since the decline in the share price and the questionable decisions by the board and mgmt to raise money at the market likely created pressure from large institutional holders for changes. MX1 fundamental analysis. Join the HotCopper ASX share market forum today for free. The price action today on KZA has opened up a great buying opportunity in my. Created with Sketch. A reversal at $0. Forums. ASX - Day Trading. Charts. 38 per share. ASX - General. 0¢ KAZIA THERAPEUTICS LIMITED - Discussion. 52, $0. . MTD achieved in St Jude study in DIPGOct 23 (Reuters) - Kazia Therapeutics Ltd (KZA) : ANNOUNCES UNCAPPED AND NOT UNDERWRITTEN SHARE PURCHASE PLAN AT $0. ASX - Day Trading. Overview. Market. . Thus the model is working so far. ASX - By Stock. Join the HotCopper ASX share market forum today for free. 0 Great analysis. 75% more bullish than other Healthcare sector stocks. 000(0. A $300M pa net profit would value KZA at say a multiple of 10 times for a market cap of $3B which would equate to a SP of. Join the HotCopper ASX share market forum today for free. . 0219 (-2. NRT/KZA own it. , page-23. ASX - By Stock. Forex. They are in phase 1 trial now and plan to undertake a pivotal phase 2 trial after which registration may be possible if results are good. . As we progress through this month and toward June, the low volume of shares traded works predominantly for the buyers. List looks rock solid to me. 52 would see the support line of the uptrend remain. ASX - General. 00%) Mkt cap ! $18. Share Sounds like JG's options, maybe it was the rejection of his 0. NSX - By Stock. The company's lead program is paxalisib, a brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. Cantrixil Part A completionI see a few posters seem to think KZA has already been awarded 2 PRVs which the company could sell any time now. 5 -1. 1 Upvote. ASX - By Stock. ASX - Day TradingGreat news - new studies continue to open! 18+100 new patients to start with. . Market . Share Details of the PNOC DIPG study design platform discussed, paxalisib and ONC-201 method of treatment arms also discussed, currently recruiting patients very well together with new study site expansions. 1d. Next stop 70 cents. There is no declaration of possible other conflicting interests. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Created with Sketch. Potential exhaustion levels for the current pullback are $0. The company is also developing EVT801, a. As a not. . 0¢ Sentiment: Hold Disclosure: Held. About the company. 2 MILLION Notification regarding unquoted securities - KZA. do not have a pass/ fail risk i. Hopefully the phase 3 results in about three years will confirm life extension. . Brain cancer being the most. . Created with Sketch. Latest Posts. Next stop 70 cents. Join the HotCopper ASX share market forum today for free. Commodities. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . ASX - General. Forums. be great if the FDA does consent to early marketing. 00%) Mkt cap ! $18. . ASX - By Stock. Kazia share purchase plan, page-2. On other threads the focus seems to have shifted to back and forth criticism of individual contributors and the company board and management. Cancer-fighting biotech Kazia Therapeutics (ASX:KZA) has received another approval from US health authorities, as it continues with phase II clinical trials for its brain cancer treatment. 0¢ Change 0. 03/11/23. KZA (ASX) Ann: Trading Halt - HotCopper. ASX - Day TradingTop 8 Medical Journalsonesurfed, maybe these can be narrowed these down further. Created with Sketch. 0 Great analysis. Market Cap $41. You can only laugh. ASX - By Stock. ASX - Day Trading. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. KZA Price at posting: 8. Potential exhaustion levels for the current pullback are $0. , page-2053. Advertise. Created with Sketch. Latest Posts. Created with Sketch. I like this KZA style but traders follow the noise to sell on the pumps and buy on the dumps - in 2015 this changed after what felt like the mother. - for cd ctc socal apch at 800-448-3724. any suggestions guysCreated with Sketch. Bank of New York Mellon purchase for the US Deposit Holders no doubt. 0. Kazia launches new SABWith a brand new year beginning my belief is the best years are ahead of us in life,I also believe Kazia may be able to give some suffering families hope. 8m, page-2. Notification regarding unquoted securities - KZA. ASX - Day TradingKZIA on Nasdaq last traded at US $3. 465. ASX - Day Trading. Latest Posts. . Latest Posts. Share Yes Rinnekin - the announcement makes reference to use of the 15% placement facility - when in fact 15 m of the total new shares came from. A reversal at $0. Market Cap $17. Heaton has taken up a new. KZA. looks like another new collaboration trial will begin some time next year… “These are very promising data,” commented Professor Rao, Principal Investigator on the project. 0¢ Sentiment: Hold Disclosure: Held. ASX - By Stock. Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has been awarded a Rare Paediatric Disease Designation (RPDD) by the US Food and Drug Administration (FDA) for the use of paxalisib in the treatment of atypical rhabdoid/teratoid tumours (AT/RT), a rare and highly aggressive childhood brain cancer. Click for more information. 52, $0. Application for quotation of securities - KZA. More likely in my mind to be a partnership and further funds injection from that type of transaction. . $0. Market . Created with Sketch. 75 yrs duration hopefully KZA will go the distance last reasonable length was 2010-2017 Helsinki Group JG is still the CEO of Kazia according to his LinkedIn profile - so he’s not been quick to update that at least. Also. , page-3. Forums. 495 and $0. That is why KZA spent the extra time and effort on pushing for a higher MTD and safety factors of GDC-0084. 3m represents about 3 quarters' of funding for operations at present levels, so KZA will head into Q1 2023 with about $4. A year or so ago, the SP was around $1. Latest Posts Forums Seeing as selected pieces of this report gets mentioned so often. Cash issues require a sufficient. 23% 16. Created with Sketch. Market Cap $37. . The material was easy to understand and the speakers were extremely knowledgeable and willing to give in-depth answers to out questions. 42. Charts. 99M. 44 - just writing that hurts for every $1,000 dollars I should. ASX - Day Trading26th Annual Meeting and Education Day of the Society for Neuro-Oncology November 18 - 21, 2021. ASX - Day TradingProposed issue of securities - KZA. Oct 11 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA ANNOUNCES INTENTION TO VOLUNTARILY DE-LIST FROM ASX SUBMITTED A FORMAL APPLICATION TO ASX TO BE. ”. ASX - By Stock. ASX - By Stock. 00 Days 00 Hours 00 Minutes 00 Seconds 2023 National Workshops in. 0¢ Sentiment: Buy Disclosure: Held. 80. From KZA 5th Aug release re RT/PAX trial: "Kazia expects to discuss emerging data from this study, along with other research in brain metastases, with its scientific advisors and regulatory consultants in due course, with potential FDA consultation at a future date. The Company primarily explores for. 3. Up nearly 35% And not showing any signs Of slowing down. KZA Price at posting: 17. 00%. , page-3. You won’t receive this rate. Recently. . Now thanks to the like of Dr Wen and other professionals not associated with the company who are happy to put their names and reputations on the line by speaking and publishing for Paxalisib. Post #: 38502115. Since the publication of SOLAR-1, we have incorporated the use of alpelisib into our patients with hormone. Regards. Join the HotCopper ASX share market forum today for free. KZA is so volatile and there is a lot of trading going on (heightened volume lately). Currency in USD Follow 2W 10W 9M 0. ASX - Day TradingLess than two weeks to go for latest Kazia results to 31 December 2019 and Kazia Chairman's letter update. , page-35. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. ASX - Day TradingCreated with Sketch. Neither Paxalisib or ONC201 are approved in any indication at this time. ASX. . . International Markets. Forums. ASX - Day Trading. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. 5¢. . ASX - By Stock. . Forums. Latest Posts. ASX - Short Term Trading. ASX - General. ASX - Day TradingCreated with Sketch. Add KZA (ASX) to my watchlist (20min delay). . Created with Sketch. Add KZA (ASX) to my watchlist. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. Latest Posts. The recently completed phase 2 trial (NCT03522298) enrolled patients with newly diagnosed GBM with unmethylated MGMT promoter status following surgical resection and chemotherapy Dr Wen and Dr De Groot were encouraged with Kazia's paxalisib phase 2 final trial results, enough to present an abstract and. 1 Upvote. Buy your tickets now limited seats. ASX - Day Trading Share Prices & Charts for KAZIA THERAPEUTICS LIMITED. Forums. ASX - By Stock. . HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. ASX - By Stock. . Notification of cessation of securities - KZA Notification regarding unquoted securities - KZA. 99M. Regards. 136. 52, $0. In the event that a combination involving paxalisib does show promising efficacy, the Page 4 Kazia Therapeutics (KZA) 14 December 2020 registration pathway would be determined by the strength of the signal and safety profile. Join the HotCopper ASX share market forum today for free. Latest Posts. It often gets busy and loud between. ASX - Day TradingCreated with Sketch. . 90M:What are they up to? Well all I can find is that both have in recent days being selling some of the holdings. 170887. ASX - By Stock. - mts w, nw, sw rwy 07 up to 280 ft msl. Kazia joins GBM Agile, page-3. Share Have any of you noticed the daily pattern of trading with KZA? It often jumps up after the open in one or two trades that occurs a few cents above the last close, but immediately following, buys and sells are entered a few cents lower with the bid a few cents below the ask. Created with Sketch. , page-35. ASX - Short Term Trading. . Market Cap $20. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of. even if the market goes on a big run I don’t think kza would run with it. Created with Sketch. ASX - Short Term Trading. . Click for more information. 8985. 80. . Latest Posts. . Trading HaltOct 28 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA THERAPEUTICS ANNOUNCES COMPLETION OF PLACEMENT OF 10 MILLION NEW FULLY PAID ORDINARY SHARES IN CO. metastasis-promoting microglia/macrophages. , page-2. Created with Sketch. 5. 52 would see the support line of the uptrend remain. Forums. Within the next few days the 2,391,865 shares issued on 30/4/21 at $1. ASX - By Stock. 1 Upvote. In one embodiment the treatment provides for a reduction in PSA score, preferably a 50%, 60%, 70%, 80%, 90% or 100% reduction in PSA score. Latest Posts. Okay guys I look for medium term trades that are 1) de-risked i. 52 would see the support line of the uptrend remain. 7. Latest Posts. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. A reversal at $0. ASX - Day Trading. ASX - By Stock. . 0000. Created with Sketch. Days Hours Minutes Seconds KZA Telehealth Solutions Center An up-to-date, comprehensive resource regarding the ever-changing telemedicine guidelines. 51pm 21/11/2023 ? HotCopper has news, discussion, prices and market data on ARCHER MATERIALS LIMITED. 495 and $0. Created with Sketch. ASX - Day Tradingmay 1 (reuters) - kazia therapeutics ltd (kza) : chief executive officer and managing director james garner has resigned john friend will immediately. , page-4. 0¢ Sentiment: Buy Disclosure: HeldKazia GDC-0084 SNO poster, page-3. , page-9. ASX - Day TradingVery impressive 2020 AGM Chairman's address and CEO presentation last Friday. The fallacy that is spread around 'it's great that they aren't reporting on time, as patients are living longer' is just that; a fallacy!Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Created with Sketch. total of $14. 2023 National Workshops in. Our strategy identified two additional CNS penetrant experimental compounds GDC-0084 and bimiralisib. Claim your IR profileCleansing noticeKazia releases preliminary Cantrixil Phase I data, page-3. It's all about the long game. ASX - Short Term Trading. ASX - General. Commodities. View the site here National Workshops More Info Webinars Watch Now Products Purchase Articles Stay Informed Coding Coaches Read KZAlerts Sign Up Interestingly John Friend’s last few appointments have a 1. Anyone can do a google search and soon come to understanding how much money is needed to get a drug into phase II trial. A $300M pa net profit would value KZA at say a multiple of 10 times for a market cap of $3B which would equate to a SP of. Market . , page-2. Latest Posts. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . ASX - By Stock. KAZIA THERAPEUTICS LIMITED - Announcements. Forums. 62 as at the end June 2022This is a reduction of 60%This in despite of the. Share HER2-positive breast cancer brain metastasis: A new and exciting landscape REVIEW - 2 July 2020. 56 to $0. Click for more information. ASX - General. Created with Sketch. Days Hours Minutes Seconds KZA Telehealth Solutions Center An up-to-date, comprehensive resource regarding the ever-changing telemedicine guidelines. ASX - Day TradingThought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. This is what it takes, in the small cap biotech sector. Kazia GDC-0084 SNO poster, page-4. 421 for the Glioblast milestone (initial announcement 31/3/21) will be out of. Created with Sketch. they need non dilutive funding to prevent wiping out shareholders, but they are far from a position of strength with any potential partners. ASX - By Stock. . All in all top 20 has again increased it. Happy to be corrected if I’m wrong. $0. of . Planning to enter the clinic in 2024 in TNBC patients. Created with Sketch. 0 Great analysis. . More. Who knows which way it will go over coming weeks. ASX - Day TradingCreated with Sketch. 40. , page-14. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. Created with Sketch. 465. Forex. Valuation. Share. Commodities. 3 Easy money to be made. MTL Mantle Minerals kicks off 15,000m. . Market . ASX - Short Term Trading. ASX - By Stock. Share To give you an idea of the growth june 2017 top was at %55 and all you needed was 160,000 to be in the top 20 Now it is 66% and you need to be over 225,000 to be in the top 20. 477 AUD for KZA. Kazia Therapeutics Limited (KZA), an ASX-listed company, is an oncology-focused drug development company, based in Sydney, Australia. Kazia licenses paxalisib to Simcere in Greater China, page-2. ASX - Day TradingKazia GDC-0084 SNO posterApplication for quotation of securities - KZA. The phase 2 trial referred to here (at bottom, for sure is Pax) - similar discussion by Prof Ellingson following his review of the Phase 1 GDC 0084 GBM trial. . 39. 52 would see the support line of the uptrend remain. As we await various study results, anyone come across research information that might help in speculating which result we may hear first and how they may. News: KZA Kazia Therapeutics Says Resignation Of Iain Ross As Chairman : Thread: Hot News: 1: 367: 0: 11/08/23: 11/08/23: ASX - By Stock: Thread: Created with. , page-2. ASX - Short Term Trading. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. ASX - Day TradingKZA is on the table because Paxlisib had better results than her older sister drugs and other current PK13 inhibitors. The estimate is that there could be sales of up to $1. Created with Sketch. Neither Paxalisib or ONC201 are approved in any indication at this time. Been.